Working... Menu

Dapagliflozin in Type 1 Diabetes (DapaT1DM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02211742
Recruitment Status : Unknown
Verified April 2015 by Markus Laimer, Medical University Innsbruck.
Recruitment status was:  Recruiting
First Posted : August 7, 2014
Last Update Posted : April 8, 2015
Medical University of Graz
University of Bern
Information provided by (Responsible Party):
Markus Laimer, Medical University Innsbruck